Eagle Pharmaceuticals, Inc. (EGRX)

Eagle Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	15.35	55.32	97.66	103.16	109.78	78.79
Cash & Short-Term Investments	15.35	55.32	97.66	103.16	109.78	78.79
Cash Growth	-58.01%	-43.35%	-5.33%	-6.03%	39.32%	-31.28%
Accounts Receivable	115.14	72.44	41.15	51.12	48	66.49
Receivables	115.14	72.44	46.46	51.12	48	66.49
Inventory	42.48	47.79	21.91	8.08	6.57	8.3
Prepaid Expenses	2.15	3.28	1.3	1.45	6.54	1.69
Other Current Assets	12.13	9.92	5.27	2.27	8.57	8.57
Total Current Assets	187.25	188.75	172.61	166.07	179.45	163.84
Property, Plant & Equipment	1.01	1.17	1.64	2.08	2.2	2.4
Long-Term Investments	18.33	10.01	6.03	12.2	-	-
Goodwill	45.03	45.03	39.74	39.74	39.74	39.74
Other Intangible Assets	115.53	126.45	10.67	12.92	15.58	18.1
Long-Term Deferred Tax Assets	30.72	27.15	18.8	15.18	13.67	13.82
Other Long-Term Assets	6.95	7.6	4.25	5.01	3.91	0.69
Total Assets	404.82	406.16	253.73	253.19	254.55	238.6
Accounts Payable	15.84	18.99	16.43	6.27	5.46	9.92
Accrued Expenses	57.45	67.59	24.05	20.74	28.36	23.52
Short-Term Debt	8.3	6.25	25.61	8	-	-
Current Portion of Long-Term Debt	-	-	-	-	5	6.25
Current Portion of Leases	1.42	1.53	1.31	1.12	-	-
Current Income Taxes Payable	1.16	5.18	-	-	-	-
Other Current Liabilities	2.46	11.54	6.98	1.95	-	-
Total Current Liabilities	86.63	111.09	74.38	38.09	38.82	39.69
Long-Term Debt	61.9	56.22	-	25.14	33.56	38.16
Long-Term Leases	0.84	1.51	-	-	-	-
Other Long-Term Liabilities	3.42	3.79	2.9	3.96	3	-
Total Liabilities	152.78	172.6	77.28	67.18	75.38	77.84
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	373.83	366.27	325.78	305.4	278.52	256.46
Retained Earnings	122.42	111.5	75.86	84.49	72.5	58.19
Treasury Stock	-243.12	-243.12	-225.11	-203.9	-171.86	-153.9
Comprehensive Income & Other	-1.11	-1.11	-0.09	-	-	-
Total Common Equity	252.04	233.56	176.45	186.01	179.17	160.76
Shareholders' Equity	252.04	233.56	176.45	186.01	179.17	160.76
Total Liabilities & Equity	404.82	406.16	253.73	253.19	254.55	238.6
Total Debt	72.45	65.51	26.92	34.26	38.56	44.41
Net Cash (Debt)	-57.1	-10.19	70.74	68.9	71.22	34.39
Net Cash Growth	-	-	2.68%	-3.26%	107.11%	-48.58%
Net Cash Per Share	-4.34	-0.78	5.42	5.00	5.04	2.25
Filing Date Shares Outstanding	12.99	13.08	12.7	13.22	13.68	13.92
Total Common Shares Outstanding	13.09	13.02	12.79	13.06	13.63	13.91
Working Capital	100.62	77.67	98.23	127.98	140.63	124.16
Book Value Per Share	19.25	17.94	13.79	14.25	13.15	11.55
Tangible Book Value	91.48	62.08	126.04	133.35	123.85	102.92
Tangible Book Value Per Share	6.99	4.77	9.85	10.21	9.09	7.40
Machinery	6.68	6.61	6.44	6.11	5.38	4.62
Leasehold Improvements	1.16	1.16	1.16	1.16	1.14	1.13

Updated Aug 8, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.